Related Experiment Video
Updated: Aug 21, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Severe ciprofloxacin-associated pseudomembranous colitis in an eight-year-old child
Carlos A Angel1, Justtin Green, Leonard Swischuk
1Department of Surgery (Pediatric Surgery), The University of Texas Medical Branch, Galveston, TX 77555-0353, USA.
Insights
Severe Clostridium difficile infection occurred in an 8-year-old child treated with oral ciprofloxacin. Fluoroquinolone use in children is not established and off-label use is discouraged.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Clostridium difficile is a primary cause of antibiotic-associated diarrhea and pseudomembranous enterocolitis in pediatric patients.
- The safety and efficacy of fluoroquinolones in children remain unestablished.
- Fluoroquinolones are a class of antibiotics often used for their broad-spectrum activity.
Observation:
- A severe case of pseudomembranous colitis developed in an 8-year-old child.
- The child had received oral ciprofloxacin as part of an investigational protocol.
- Ciprofloxacin is a fluoroquinolone antibiotic.
Findings:
- The case demonstrates a potential risk of severe Clostridium difficile infection associated with fluoroquinolone use in children.
- Antibiotic-associated colitis can manifest severely even in pediatric populations.
- The development of pseudomembranous enterocolitis highlights the disruption of normal gut flora.
Implications:
- Clinicians should exercise caution when considering fluoroquinolone therapy for pediatric patients.
- Off-label use of fluoroquinolones in children, particularly as oral antipseudomonas agents, is strongly discouraged outside of approved investigational protocols.
- Further research is needed to establish the safety profile of fluoroquinolones in pediatric populations.
Abstract:
Clostridium difficile is the principal cause of antibiotic-associated diarrhea and pseudomembranous enterocolitis in children. A case of severe pseudomembranous colitis developing in an 8-year-old child who had received oral ciprofloxacin therapy as part of an investigational protocol is presented. The safety and efficacy of fluoroquinolones in children has not yet been established. Use of these antibiotics in children outside investigational protocols ("off-label" use) as oral antipseudomonas agents is discouraged.
Related Concept Videos
Bacterial Gastroenteritis
Rocky Mountain Spotted Fever
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Cryptococcal Meningitis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
